Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Regorafenib
Australian Public Assessment Report
Device/Product Name
Stivarga
Active ingredients
Regorafenib
AusPAR Date
Published
Sponsor
Submission Number
PM-2016-04269-1-4
Submission Type
Extension of indications
Decision
Approved